IBS Capital LLC

-

Assets, Funds, Holdings

Home | Sign Up | Log In
New Features
Latest Fund Raises
Related People
Fund Service Providers
Startup & Company Raises
List of Funds
Boston Firms
Boston Hedge Funds
Cornell Alumni Firms
CalPERS Portfolio
NYSCRF Portfolio
User Guide
Regulatory AUM vs AUM
LP Portfolios
Related Firms
Build a Portfolio
Comprehensive Search
Keyboard
IBS Capital LLC
CRD #160585
SEC #801-74238
CIK #0001414860
AUM 123.0 M (2026-04-27)
Employees 4 (50% Investors, 0% Brokers)
Fees
Minimum
Phone617-261-5327
Address266 Main Street
Medfield, MA 02052
Source [IAPD] [EDGAR] [Website]
Total AUM ($M)
3002401801206002010201520212027
Fees and Compensation — Form ADV Part 2A (3/24/2026) [Brochure]
Item 5 – Fees and Compensation

For each Fund, a 1.5% annual management fee is paid quarterly in arrears, in lieu of reimbursing
IBS for office space, utilities, administrative services, etc. IBS is allocated an annual
performance share equal to twenty percent of the appreciation credited to the accounts of the
investors subject to a high water mark. The management fee and any prior years' losses must be
earned back before a performance share may be earned. Management fees are deducted directly
from the capital accounts of the investors.

Each individual Fund bears its costs for research fees; interest on margin accounts; ongoing legal,
audit and accounting fees; borrowing charges for securities sold short; custodial fees; brokerage
commissions; bank service fees; interest on loans and debit balances; and any other reasonable
expenses related to the purchase, sale or transmittal of the Fund assets, as IBS shall determine in
its sole discretion. For more information on brokerage and transaction costs, refer to Item 12.
Account Minimums and Types of Clients — Form ADV Part 2A (3/24/2026) [Brochure]
Item 7 – Types of Clients

IBS is the general partner of The IBS Turnaround Fund, L.P. and is solely responsible for making
all investment and related decisions for the fund. The IBS Turnaround Fund, L.P. is designed for
U.S. domiciled, “accredited” investors. IBS also manages a sister fund, The IBS Turnaround
Fund (QP) (A Limited Partnership), an identical fund designed for “Qualified Purchasers.” Both
funds pursue an identical strategy and hold virtually identical portfolios of investments.

As both Turnaround Funds aggressively focus on maximizing their after-tax returns, they are best
suited for taxable, U.S. domiciled investors. U.S. tax-exempt investors as well as offshore
investors may invest through an offshore sister fund, The IBS Opportunity Fund Ltd., a Bahamian
corporation. The Opportunity Fund pursues a similar investment strategy, but focuses on
maximizing its pre-tax return. Typically, the Opportunity Fund will hold many of the same
investments as The IBS Turnaround Funds, but does not maintain an identical portfolio.

The minimum investment is $1,000,000 for the Turnaround Funds and $500,000 for the
Opportunity Fund. Investments are subject to a one-year lockup. Types of investors include
individuals (must be “accredited” investors), family offices, corporations, investment funds and
trust, and institutional investors including endowments and foundations.
Type Form D Funds Date Sold AUM
HF The IBS Opportunity Fund Ltd [2012-02-15] 25.7 M 11.6 M
Filed 2025-02-10 (D/A) · Exemption 506(b), 3(c), 3(c)(1) · Minimum $500,000 · Remaining Indefinite · Duration More than one year · Net Assets Decline to Disclose
HF The IBS Turnaround Fund LP 2012-02-15 38.1 M
HF The IBS Turnaround Fund QP A Limited Partnership [2012-02-15] 247.1 M 73.3 M
Filed 2025-12-04 (D/A) · Exemption 506(b), 3(c), 3(c)(7) · Minimum $1,000,000 · Remaining Indefinite · Duration More than one year · Net Assets Decline to Disclose
AUM Breakdown Accounts AUM ($M)
By Client Type
(a) Individuals (other than high net worth individuals) 0 0.0
(b) Individuals (high net worth individuals) 0 0.0
(c) Banking or thrift institutions 0 0.0
(d) Investment companies 0 0.0
(e) Business development companies 0 0.0
(f) Pooled investment vehicles 3 123.0
(g) Pension and profit sharing plans 0 0.0
(h) Charitable organizations 0 0.0
(i) State or municipal government entities 0 0.0
(j) Other investment advisers 0 0.0
(k) Insurance companies 0 0.0
(l) Sovereign wealth funds and foreign official institutions 0 0.0
(m) Corporations or other businesses not listed above 0 0.0
(n) Other 0 0.0
Total 3 123.0
By Discretionary
Discretionary 3 123.0
Non-Discretionary 0 0.0
Total 3 123.0
By Non-United States Persons
Non-United States Persons 11.6
United States Persons 111.4
Total 3 123.0
Form D Directors Role # Filings # Firms 2011 - 2026
Shonalee Munroe Director 3 3
David Blair Director 19 2
David Taft Director, Executive Officer 14 2
James Horne Director 3 2
Theresa Taft Director 2 2
Izabella Koeijers Director 1 1
EDGAR Form CIK 2011 - 2026
4 [0001414860]
SC 13G [0001414860]
Form 13D/13G Filer Form 13D/13G Subject Filed
IBS Capital LLC AGEX Therapeutics Inc [2019-02-14]
Firm Profile (Form ADV)
Discretionary AUM$0.2B
ServesInstitutional
Fund TypesHedge Fund
LEI549300PG3UL61E645164
Form 3/4/5 Subject 2011 - 2026
Taft David A
IBS Capital LLC
IBS Turnaround Fund QP A Ltd Partnership
Applied Minerals Inc
Insider Transaction (Form 3/4/5) Date Action Shares Price Value ($)
Applied Minerals Inc AMNL
10% PIK-Election Convertible Note · derivative
2021-12-17 Sell 1
Applied Minerals Inc AMNL
Common Stock
2021-12-17 Sell 3,597,000 $0.01 35,970
Applied Minerals Inc AMNL
Common Stock
2021-12-17 Sell 1,403,000 $0.01 14,030
Applied Minerals Inc AMNL
10% PIK-Election Convertible Note · derivative
2021-12-17 Sell 1
Applied Minerals Inc AMNL
10% PIK-Election Convertible Note · derivative
2021-12-17 Sell 1
Applied Minerals Inc AMNL
Warrant (right to buy) · derivative
2017-12-14 Buy 58,401
Applied Minerals Inc AMNL
PIK - Election Convertible Note due 2018 · derivative
2017-12-14 Disposed to issuer
Applied Minerals Inc AMNL
PIK - Election Convertible Note due 2018 · derivative
2017-12-14 Disposed to issuer
Applied Minerals Inc AMNL
PIK - Election Convertible Note due 2023 · derivative
2017-12-14 Other
Applied Minerals Inc AMNL
Warrant (right to buy) · derivative
2017-12-14 Buy 601,060
Applied Minerals Inc AMNL
Warrant (right to buy) · derivative
2017-12-14 Buy 299,317
Applied Minerals Inc AMNL
PIK - Election Convertible Note due 2023 · derivative
2017-12-14 Other
Applied Minerals Inc AMNL
PIK - Election Convertible Note due 2018 · derivative
2017-12-14 Disposed to issuer
Applied Minerals Inc AMNL
PIK - Election Convertible Note due 2023 · derivative
2017-12-14 Other
Applied Minerals Inc AMNL
Stock Option (right to buy) · derivative
2017-05-24 Grant 50,000 $0.00
Applied Minerals Inc AMNL
Common Stock
2017-05-23 Grant 50,000 $0.00
Applied Minerals Inc AMNL
Stock Option (right to buy) · derivative
2017-05-23 Grant 50,000 $0.00
Applied Minerals Inc AMNL
Stock Option (Right to Buy) · derivative
2016-08-01 Grant 50,000 $0.00
Applied Minerals Inc AMNL
Common Stock
2016-06-24 Buy 1,333,334 $0.15 200,000
Applied Minerals Inc AMNL
Warrant (Right to Buy) · derivative
2016-06-24 Buy 1,333,334
showing 20 of 44 most recent transactions
Comparable Firms State AUM
P&A Capital Advisors Inc
NY 126.4 M
Southpaw Asset Management LP
125.1 M
Landmark Investment Partners LP
FL 124.9 M
Emergent Capital Advisors LLC
TX 124.1 M
Caprice Capital Partners LLC
123.2 M
Arkhouse Management Co LP
NY 122.9 M
Silver Creek Capital Management LLC
WA 122.5 M
Cambrian Asset Management Inc
CA 121.8 M
Weber Capital Management LLC
120.2 M
Marathon Partners Equity Management LLC
NY 120.1 M
Terms | Privacy | Providers | Companies | Guide
tony@aum13f.com